OMER Q1 2026 Earnings EPS Beats Estimates as Operating Expenses Decline But Stock Falls on Lack of Revenue IMMX Q1 2026 Earnings Narrowed Loss as Biotech Advances Oncology Pipeline Stantec Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher BBY Q1 2026 Earnings Solid EPS Beat Amidst Consumer Electronics Landscape Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline GFL Q1 2026 Earnings EPS Misses Estimates Amidst Cost Pressures